31 min
Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer Keeping Current CME
-
- Medicine
How do you define high-risk for recurrence in breast cancer?
Credit available for this activity expires: [03/27/25]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000352?ecd=bdc_podcast_libsyn_mscpedu
How do you define high-risk for recurrence in breast cancer?
Credit available for this activity expires: [03/27/25]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000352?ecd=bdc_podcast_libsyn_mscpedu
31 min